Comparative Effectiveness for AI MedTech
Published on: 04/09/2024
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
Payer Coverage
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after.
A breakdown of the finalized TCET rule and what it means for Breakthrough Devices.
A review of what peer-reviewed publications reveal about payer adoption of AI tools.